Attention seniors! It’s never too late to stop smoking
Quitting smoking even as late as at 75 years of age can meaningfully increase a person’s life expectancy, according to a new study in the American Journal of… read more.
Quitting smoking even as late as at 75 years of age can meaningfully increase a person’s life expectancy, according to a new study in the American Journal of… read more.
GE HealthCare announced that the FDA has granted approval of Flyrcado (flurpiridaz F 18) injection, a first of its kind positron emission tomography myocardial perfusion imaging (PET MPI)… read more.
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol water-free technology, and Laboratoires Théa (Théa), the leading independent eye care group… read more.
A new study led by researchers at Queen Mary University of London reveals women would welcome the option to choose between self-sampling and traditional screening done by a… read more.
GSK plc announced new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating the efficacy of a single dose of Arexvy (respiratory syncytial virus vaccine,… read more.
A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal… read more.
Medtronic plc, a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700… read more.
A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such as Wegovy and Ozempic. The survey was conducted by… read more.
Positive high-level results from the BATURA Phase IIIb trial showed AstraZeneca’s Airsupra (albuterol/budesonide) met the primary endpoint, demonstrating a statistically significant and clinically meaningful reduction in the risk… read more.
A randomized control trial of adults with metabolic syndrome evaluated the effect of time-restricted eating (TRE) on glucose control, fat mass, and weight loss. The data revealed that… read more.
Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels. Smoking continues to be a leading cause of premature death,… read more.
UCB, announced the first presentation of two-year data from the Phase III studies, BE HEARD I and BE HEARD II, and their open-label extension, evaluating the efficacy and… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.